- Accesswire•last month
FAIRFIELD, CT / ACCESSWIRE / August 24, 2016 / Calmare Therapeutics Incorporated , (OTCQB: CTTC) (CTI), the pain mitigation company, reported results for the six months and three months ended June 30, ...
- Capital Cube•3 months ago
Click here to see latest analysisCalmare Therapeutics, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Calmare Therapeutics, Inc. – RPX Corporation and Lionbridge Technologies, Inc. (RPXC-US and LIOX-US) that have also reported for this period.HighlightsSummary numbers: Revenues of USD 0.06 million, Net Earnings […] (Read more...) The post Calmare Therapeutics, Inc. :CTTC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 appeared first on CapitalCube.
- Accesswire•4 months ago
Date: Tuesday, May 31, 2016; Venue: Convene, 730 Third Avenue, New York City FAIRFIELD, CT / ACCESSWIRE / May 25, 2016 / Calmare Therapeutics Incorporated (OTCQB: CTTC) (CTI), the pain mitigation company, ...
Calmare Therapeutics Incorporated (CTTC)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.15 - 0.16|
|52wk Range||0.13 - 0.24|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.16|
|Avg Vol (3m)||14,934|
|Dividend & Yield||N/A (N/A)|